Related Experiment Video
Updated: Jun 10, 2026
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Stable angina pectoris: what does the current clinical evidence tell us?
1Department of Internal Medicine, Division of Cardiovascular Disease, University of Michigan Medical Center, Ann Arbor, MI, USA. kentobin@umich.edu
Insights
Coronary artery disease (CAD) management is shifting towards personalized risk assessment and lifestyle changes. Aggressive treatment of hypertension and hyperlipidemia, alongside patient involvement, is key for optimal care and reducing healthcare costs.
Area of Science:
- Cardiovascular Medicine
- Preventive Cardiology
- Health Economics
Background:
- Coronary artery disease (CAD) remains the leading cause of mortality in the United States.
- Cardiovascular diagnostic and interventional procedures represent a significant portion of national healthcare spending.
- Accurate diagnosis of ischemically-driven chest pain requires clinical expertise to identify significant coronary artery blockage.
Purpose of the Study:
- To emphasize the importance of comprehensive risk factor management in CAD.
- To advocate for a shift in treatment paradigms for coronary artery disease.
- To highlight the role of patient-centered care in managing cardiovascular health.
Main Methods:
- Review of current cardiovascular research and clinical evidence.
- Analysis of healthcare expenditure related to cardiovascular testing and procedures.
- Emphasis on risk factor assessment including hypertension, hyperlipidemia, blood glucose, and lifestyle factors.
Main Results:
- Aggressive management of hypertension and hyperlipidemia is crucial for optimal patient care.
- A comprehensive management plan incorporating blood glucose assessment, smoking cessation, weight management, diet, and exercise is essential.
- Current trends suggest a move away from routine percutaneous coronary interventions.
Conclusions:
- Future cardiovascular care will likely prioritize aggressive cardiac risk profiling.
- Treatment plans will increasingly focus on active patient engagement, lifestyle modifications, and targeted pharmacotherapy.
- This approach aims to improve patient outcomes and potentially reduce healthcare costs associated with CAD.
Abstract:
Coronary artery disease is the leading cause of death in the United States. The combination of noninvasive cardiovascular testing and invasive cardiac procedures accounts for a substantial portion of the yearly healthcare expenditure in the United States. Although the diagnosis of ischemically-driven chest pain may appear to be simple and straightforward, it often takes an astute clinician to confirm that clinically significant coronary artery blockage is the cause of a patient's chest pain. Cardiovascular research has provided convincing evidence that aggressive treatment of hypertension and hyperlipidemia--along with a management plan, based on the patient's combined risk factor profile, that includes blood glucose assessment, tobacco cessation, weight loss, healthy eating choices, and consistent aerobic exercise--must be provided to achieve optimal care for our patients. Over the ensuing decade, we will likely continue to see a shift away from routine percutaneous treatment of coronary lesions in favor of an aggressive assessment of a patient's cardiac risk profile followed by a treatment plan centered on active patient involvement including appropriate lifestyle changes and selective medications.
More Related Videos
Related Concept Videos
01:29Angina III: Clinical Manifestations and Assessment
01:27Angina II: Classification
01:20Angina V: Nursing Management
01:30Angina I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:26Angina IV: Management